Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 77,722 $ 44,464
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 135,617 116,449
Deferred income taxes 12,505 5,864
Share-based compensation 18,698 22,171
Non-cash rent expense 13,650 17,630
Impairment charges associated with long-lived assets 1,420 1,280
(Gain) loss on disposal of property and equipment, net (11,067) 904
Amortization of debt discounts and issuance costs 4,006 3,919
Changes in operating assets and liabilities 5,642 6,734
Other 2,637 (3,124)
Net cash provided by operating activities 260,830 216,291
Cash flows from investing activities:    
Capital expenditures (301,107) (337,076)
Proceeds from Sale of Other Property, Plant, and Equipment 142,671 78,040
Proceeds from the sale of land 6,328 0
Other (2,173) (462)
Net cash used in investing activities (154,281) (259,498)
Cash flows from financing activities:    
Proceeds from borrowings 0 44,291
Repayments of debt (67,647) (7,430)
Proceeds from revolving credit facility 670,000 620,000
Repayments of revolving credit facility (695,000) (620,000)
Repayments of finance lease liabilities (403) (508)
Proceeds from financing obligations 4,300 0
Payments of debt discounts and issuance costs 0 (2,550)
Proceeds from stock option exercises 1,490 13,276
Proceeds from issuances of common stock in connection with the employee stock purchase plan 1,462 1,450
Other (1,304) (109)
Net cash (used in) provided by financing activities (87,102) 48,420
Effect of exchange rates on cash and cash equivalents and restricted cash and cash equivalents (55) 136
Increase in cash and cash equivalents and restricted cash and cash equivalents 19,392 5,349
Cash and cash equivalents and restricted cash and cash equivalents – beginning of period 29,966 25,509
Cash and cash equivalents and restricted cash and cash equivalents – end of period $ 49,358 $ 30,858